AGM three-lens brief
Evidence-based stock research on AGM. Three independent lenses — Foundation, Expansion, Climate — examine live data from SEC filings, the Federal Reserve, and market feeds. Every claim traces to its primary source.
Performance
Underperforming SPY by 15.5pp over 30 days. · Trading >3% below the 50-day MA — short-term weakness.
- Trading >3% below the 50-day MA — short-term weakness.
- RSI at 25 — technically oversold.
- Underperforming SPY by 15.5pp over 30 days.
- P/E of 9.2 — trading at a value multiple.
- Analyst mean target $257.00 — 48% above current (3 analysts).
AGM closed at $174.10 (+0.30%) as of 2026-11-12. Market cap: $1.89B. P/E (trailing) 9.2. Price is below the 50-day MA and below the 200-day MA. Positives: p/E of 9.2 — trading at a value multiple.; analyst mean target $257.00 — 48% above current (3 analysts).. Concerns: trading >3% below the 50-day MA — short-term weakness.; rSI at 25 — technically oversold.. Last quarter: Revenue $122.73M, net income $54.88M.
Why three lenses on AGM, not one.
A single reasoning model has blind spots it doesn’t know about. We examine AGM across Foundation (fundamentals), Expansion (growth runway and market expansion), and Climate (macro/sector). Disagreement between lenses is surfaced, not hidden — it’s how you know when HOLD is the honest call.
Read the full methodologyDrop it in your newsletter or blog.
Free to embed. Updates every 6 hours. Links back to the full brief.
<iframe src="https://www.clearpathinvest.app/embed/AGM" width="100%" height="420" frameborder="0" loading="lazy" title="ClearPath AGM brief"></iframe>